Decellularization of various tissues and organs through chemical methods

Tissue Cell. 2024 Dec:91:102573. doi: 10.1016/j.tice.2024.102573. Epub 2024 Oct 5.

Abstract

Due to the increase in demand for donor organs and tissues during the past 20 years, new approaches have been created. These methods include, for example, tissue engineering in vitro and the production of regenerative biomaterials for transplantation. Applying the natural extracellular matrix (ECM) as a bioactive biomaterial for clinical applications is a unique approach known as decellularization technology. Decellularization is the process of eliminating cells from an extracellular matrix while preserving its natural components including its structural and functional proteins and glycosaminoglycan. This can be achieved by physical, chemical, or biological processes. A naturally formed three-dimensional structure with a biocompatible and regenerative structure is the result of the decellularization process. Decreasing the biological factors and antigens at the transplant site reduces the risk of adverse effects including inflammatory responses and immunological rejection. Regenerative medicine and tissue engineering applications can benefit from the use of decellularization, a promising approach that provides a biomaterial that preserves its extracellular matrix.

Keywords: Acellularization; Enzymatic; Extracellular matrix; Physical; Tissue.

Publication types

  • Review

MeSH terms

  • Animals
  • Biocompatible Materials / chemistry
  • Decellularized Extracellular Matrix / chemistry
  • Extracellular Matrix / chemistry
  • Glycosaminoglycans / metabolism
  • Humans
  • Regenerative Medicine
  • Tissue Engineering* / methods
  • Tissue Scaffolds / chemistry

Substances

  • Decellularized Extracellular Matrix
  • Biocompatible Materials
  • Glycosaminoglycans